LALLEMAND Animal Nutrition announced Jan. 7 that it acquired Microbial Developments Ltd., the U.K.-based manufacturer of Aviguard, effective Dec. 31, 2012.
Lallemand acquired Microbial Developments from Tim Nelson, who originally purchased the business from Bayer PLC in 1995 as a management buyout.
Nelson will continue to act as managing director. Sue Reynolds, sales and marketing director, will continue to manage global distributor relationships and business development for Aviguard.
As part of the transaction, Lallemand also acquired Microbial Developments' Aviguard and lactic acid bacteria fermentation plants, packing and research and development facilities in Malvern, U.K. Under Lallemand's ownership, the business will continue to produce lactic acid bacteria from the Malvern facility for third-party customers as well as for Lallemand's own needs.
Aviguard is an avian competitive-exclusion product that aids the rapid establishment of normal gut flora in day-old chicks, thereby minimizing colonization by transient pathogenic bacteria such as salmonella, Escherichia coli and Clostridium perfringens, the announcement said.
The product is sold in more than 36 countries and is widely used in broiler and layer breeders, parent stock and grandparent stock, Lallemand said.
Lallemand Animal Nutrition is dedicated to the development, production and marketing of natural and differentiated solutions for animal nutrition and health. Its core products include live bacteria for probiotics and silage inoculants, specific yeast for probiotics and high-value yeast derivatives.
Lallemand is a privately owned Canadian company that specializes in the research, development, production, marketing and distribution of yeast and bacteria for use in the animal nutrition, baking, beverage and pharmaceutical industries.
In addition to the newly acquired Malvern facility, Lallemand has existing plants in Milwaukee, Wis.; St. Simon, France, and Montreal, Que.